Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2023 Earnings Call Transcript
Trevi Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.1.
Trevi Therapeutics Inc. (TRVI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 5,684,420 | $7,617,123 | 0.15% | |
| 2. | Viking Global Andreas Halvorsen | 4,400,000 | $5,896,000 | 0.02% | |
| 3. | Opaleye Management James A. Silverman | 2,535,000 | $3,396,900 | +49% | 0.9% |
| 4. | Checkpoint Capital Sam Huang | 1,292,316 | $1,731,703 | 1.04% | |
| 5. | SilverArc Capital Devesh Gandhi | 863,883 | $1,157,603 | -7% | 0.34% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.90 | 948,948 | Large Shareholder | 948,948 | 2022-04-11 | Filing | |
| $1.90 | 2,631,578 | Large Shareholder | 10,421,428 | 2022-04-11 | Filing | |
| $1.90 | 948,948 | Large Shareholder | 948,948 | 2022-04-11 | Filing | |
| $1.90 | 2,631,578 | Large Shareholder | 10,421,428 | 2022-04-11 | Filing | |
| $1.90 | 948,948 | Large Shareholder | 948,948 | 2022-04-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.02 | 785 | Officer | 35,901 | 2023-10-11 | Filing | |
| $2.20 | 711 | Officer | 34,394 | 2023-09-11 | Filing | |
| $2.36 | 682 | Officer | 32,814 | 2023-08-11 | Filing | |
| $2.34 | 687 | Officer | 31,204 | 2023-07-11 | Filing | |
| $2.64 | 610 | Officer | 29,599 | 2023-06-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,370,376 | $15,236,304 | 1.01% | |
| 2. | 7,381,090 | $9,890,661 | 0.52% | |
| 3. | 3,422,397 | $4,586,012 | 0.31% | |
| 4. | 2,319,716 | $3,108,419 | 0% | |
| 5. | 2,243,399 | $3,006,154 | 0% |
News See All
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Trevi Therapeutics Q3 2023 Earnings Conference Call. At this time all participants will be in a listen-only mode.
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Trevi Therapeutics’ Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q1 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Trevi Therapeutics’ Q1 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2022 Earnings Call Transcript
Operator: Good afternoon and welcome to the Trevi Therapeutics Q4 and Year-End 2022 Earnings Conference Call. Please note this event is being recorded.